ACIP: COVID-19 Vaccine Should Be Offered to HCPs, LTC Residents First
The recommendation was made based on the number of confirmed COVID-19 cases among these 2 groups, as well as ethical and scientific considerations.
COVID19
Risk for SARS-CoV-2 Infection Lower for O, Rh− Blood Groups
Also, risk for severe COVID-19 illness or death lower for O vs all other groups, for Rh− vs Rh+.
FDA Authorizes Use of Monoclonal Antibody Treatment for COVID-19
IV infusion of casirivimab and imdevimab authorized for treatment of mild-to-moderate COVID-19.
Management of AL Amyloidosis, Immunoglobulin Deposition Disease During the COVID-19 Pandemic
The management of AL amyloidosis and immunoglobulin disease during the COVID-19 pandemic should be individualized based on several patient-specific aspects.
FDA Authorizes COVID-19 Test That Provides Rapid Results at Home
This is the first time the Agency has authorized a COVID-19 diagnostic test that provides rapid results at home.
Serum Antiphospholipid, Phospholipid-Binding Protein Antibodies in Coronavirus Disease 2019
Prothrombotic autoantibodies, similar to those with antiphospholipid syndrome, appear to be elevated in hospitalized patients with COVID-19.
Predictors of Worse Outcomes Identified for Patients With COVID-19 and Myeloma
Age, high-risk disease, renal disease, and active or progressive disease were predictive of worse outcomes for patients with multiple myeloma and COVID-19.
Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Near 95% Effective
The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.
Venous Thromboembolism Rates in Patients With SARS-CoV-2 Infection
In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.
Multicenter Study of Spanish Patients Provides New Insights on COVID-19 in Multiple Myeloma
In addition to age, sex, and comorbidities, a new study flagged uncontrolled cancer and renal insufficiency as key prognostic factors for COVID-19 outcomes.
-
Loading...
-
Loading...
Next post in Myeloma
